Abstract
Cardiovascular diseases [CVD] is one of the main cause of death and disability that can be prevented by leading a healthy lifestyle. Bioactive compounds from natural marine sources have gained a lot of interest. Marine sources serve as reservoirs for new bioactive metabolites with various pharmacological activities. Innumerable products derived from marine sources have been widely used across the globe by traditional practitioners for thousands of years. Marine pharmacology has been reviewed extensively in the past all over the world as well as India, but still there is a need to review the potential of the oceans as sources for the development of new drugs, considering the advantage of their abundance in natural and large scale production. The marine derived compounds such as Omega 3 acid ethyl ester, Xyloketal B, Asperlin, Saringosterol, chitooligosaccarides, Phlorotannins, Alginate oligosaccharides, Astaxanthin, Fucoxanthin, Zeaxanthin, Alginate, Carrageenan, Fuciodan, Phloroglucinol, Arachidonic acid, Lycopene, Saponins, Deep sea water, Terpenes, Sponge extract, Ulvan, Chitosan showed promosing results in several CVD's. Marine molecules show unique structural features and exhibit various types of biological activities. Marine natural drugs depict a high safety profile, wide range of biological activities and natural origin. They are novel over synthetic drugs for the minimization of adverse effects in CVD's and associated complications. They are preferable to other products due to their low toxicity, chemical variety, economic effectiveness and demonstrated therapeutic promise.